RadNet, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
RadNet, Inc. (RDNT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 1.11% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-03-02
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 1.11%, a 85.00% increase from fiscal 2024.
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was 0.60%, a 25.00% decline from fiscal 2023.
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was 0.80%.
- RadNet, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2016 was -25.25%, a 288.29% decline from fiscal 2015.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.11% 10-K · filed 2026-03-02 | |
| 2024-12-31 | 0.60% 10-K · filed 2026-03-02 | |
| 2023-12-31 | 0.80% 10-K · filed 2026-03-02 | |
| 2016-12-31 | -25.25% 10-K · filed 2017-03-17 | |
| 2015-12-31 | 13.41% 10-K · filed 2017-03-17 | |
| 2014-12-31 | 16.34% 10-K · filed 2017-03-17 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-15 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-16 | 11.28% 10-K · filed 2013-03-18 |
| 2011-12-31 | 14.40% 10-K · filed 2013-03-18 | |
| 2010-12-31 | -7.76% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |